Search Results - "BREMA, F"

Phase-II study of Navelbine in advanced breast cancer by Canobbio, L, Boccardo, F, Pastorino, G, Brema, F, Martini, C, Resasco, M, Santi, L

Get more information

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer by ARDIZZONI, A, VENTURINI, M, SILVESTRO, S, BRUZZI, P, LIONETTO, R, LATINI, F, ROSSO, R, SERTOLI, M. R, GIANNESSI, P. G, BREMA, F, DANOVA, M, TESTORE, F, MARIANI, G. L, PEENUCCI, M. C, QUEIROLO, P

“…A randomised study was conducted in 62 patients with advanced breast cancer to assess whether granulocyte-macrophage colony-stimulating factor (GM-CSF) would…”
Get full text

Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial by Merlano, M, Corvo, R, Margarino, G, Benasso, M, Rosso, R, Sertoli, M R, Cavallari, M, Scala, M, Guenzi, M, Siragusa, A

“…Between 1983 and 1986, the National Institute for Cancer Research in Genoa and affiliated institutions conducted a randomized study to compare two different…”
Get more information

High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule by BALLESTRERO, A, FERRANDO, F, BREMA, F, MELA, G. S, SESSAREGO, M, PATRONE, F, GARUTI, A, BASTA, P, GONELLA, R, ESPOSITO, M, VANNOZZI, M. O, SORICE, G, FRIEDMAN, D, PUGLISI, M

“…The optimal use of mitoxantrone (NOV) in the high-dose range requires elucidation of its maximum tolerated dose with peripheral blood progenitor cell (PBPC)…”
Get full text

Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial by Venturini, Marco, Del Mastro, Lucia, Aitini, Enrico, Baldini, Editta, Caroti, Cinzia, Contu, Antonio, Testore, Franco, Brema, Fulvio, Pronzato, Paolo, Cavazzini, Giovanna, Sertoli, Mario Roberto, Canavese, Giuseppe, Rosso, Riccardo, Bruzzi, Paolo

“…Background: To determine whether a dose-dense regimen improves outcome in early breast cancer patients, we compared outcomes with the same fluorouracil,…”
Get full text

Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer by Patrone, F, Ballestrero, A, Ferrando, F, Brema, F, Moraglio, L, Valbonesi, M, Basta, P, Ghio, R, Gobbi, M, Sessarego, M

“…High-dose chemotherapy produces high complete remission (CR) rates and some survival advantage in patients with metastatic breast cancer (BC). A current issue…”
Get more information

Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study by Boccardo, F., Amoroso, D., Iacobelli, S., Irtelli, L., Farris, A., Mustacchi, G., Mesiti, M., Brema, F., Pacini, P., Cortesi, E., Nardini, P., Guida, G., Langenaeken, C.

“…Background Aminoglutethimide was the first aromatase inhibitor to be used successfully in breast cancer patients. However, this drug also inhibits…”
Get full text

High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial by Mustacchi, G, Pavesi, L, Milani, S, Iaffaioli, V, Caraco, A, Comella, G, Contu, A, Farris, A, Attado-Parinello, G, Narcisi, M

“…The purpose of this study was to ascertain the possible protective effect of thymostimulin (TS) on chemotherapy-induced leukopenia and related febrile…”
Get more information

High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells by Patrone, F, Ballestrero, A, Balleari, E, Bogliolo, F, Brema, F, Ferrando, F, Ghio, R, Timitilli, S

“…Several methods for the recruitment of circulating progenitor cells (CPC) to be used for hemopoietic rescue after myeloablative therapy have been described…”
Get more information

Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial by Brema, F, Pastorino, G, Martini, M C, Gottlieb, A, Luzzani, M, Libretti, A, Saccà, L, Cigolari, S

“…In this multicentre trial tramadol and buprenorphine were compared for the treatment of neoplastic pain no longer responsive to non-steroidal antiinflammatory…”
Get more information

Combination of epirubicin and lonidamine for treatment of advanced breast cancer by Moraglio, L, Brema, F, Pastorino, G, Martini, M C, Vallauri, M

“…In vitro and in vivo studies have shown that lonidamine potentiates the cytotoxic effect of anthracyclines in simultaneous and sequential combination. On the…”
Get more information

Stimulation of human breast cancer in vivo. Experimental findings and clinical results by Baldini, E, Gardin, G, Naso, C, Pronzato, P, Rosso, R, Rubagotti, A, Monzeglio, C, Brema, F, Pastorino, G, Amadori, D

Get more information

Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer by Sobrero, A, Nobile, M T, Guglielmi, A, Mori, A, Aschele, C, Bolli, E, Tixi, L, Gallo, L, Parodi, G C, Bruzzi, P

“…15 untreated patients with advanced measurable colorectal cancer along with other 29 patients in progression after failing first line chemotherapy with…”
Get more information

In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results by Conte, P F, Gardin, G, Pronzato, P, Miglietta, L, Rosso, R, Amadori, D, Gentilini, P, Monzeglio, C, Gallotti, P, Demicheli, R

“…Since 1983, a series of experimental and clinical studies have been carried out on the possibility of enhancing the chemotherapy effectiveness in breast cancer…”
Get more information

Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial by Rosso, R, Boccardo, F, Brema, F, Sertoli, M R, Amoroso, D, Bertelli, G, Pronzato, P

“…131 patients with resectable, node-positive breast cancer were treated at the National Institute for Cancer Research of Genoa, Italy with a systemic adjuvant…”
Get more information

Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group by Del Mastro, L., Dozin, B., Aitini, E., Catzeddu, T., Baldini, E., Contu, A., Durando, A., Danese, S., Cavazzini, G., Canavese, G., Bruzzi, P., Pronzato, P., Venturini, M.

“…Background: The timing of adjuvant chemotherapy and tamoxifen (TAM) has been investigated only in postmenopausal women with breast cancer. We analyzed the…”
Get full text

Effects of irradiation and storage on granulocytes harvested by continuous-flow centrifugation by Patrone, F, Dallegri, F, Brema, F, Sacchetti, C

“…Five normal subjects were subjected to leukapheresis by continuous-flow-centrifugation (CFC) in the Aminco Celltrifuge. Granulocyte functional capacities were…”
Get more information

Cardiac arrhythmia: possible complication from treatment with cisplatin by Canobbio, L, Fassio, T, Gasparini, G, Caruso, G, Barzan, L, Comoretto, R, Brema, F, Villani, F

“…Cardiotoxicity is rarely observed during cisplatin chemotherapy. A possible synergistic toxic effect of cisplatin with etoposide on cardiac electrical activity…”
Get more information

Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors by Nobile, M T, Rosso, R, Brema, F, Cinquegrana, A, Santi, L

“…Thirty six patients with advanced solid tumors (24 lung: 3 oat-cell, 14 squamous, 7 adenocarcinomas, 3 soft tissue sarcomas, 6 breast carcinomas; 1 seminoma; 2…”
Get more information

P-584 Single agent gemcitabine (GEM) in performance status (PS) 2–3patients (pts) with advanced non-small cell lung cancer (NSCLC): Effect on disease-related symptoms in a multicenter phase II trial by Tiseo, M., Tognoni, A., Carob, C., Mencoboni, M., Pennucci, M., Coialbu, T., Brema, F., Grossi, F., Pronzato, P., Ardizzoni, A.

Get full text